Bilici, A. Et Al. 2023. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study. Journal of Cancer Research and Clinical Oncology , vol.149, no.11 , 8243-8253.

Bilici, A., Koca, S., Karaagac, M., Aydin, S. G., Eraslan, E., Kaplan, M. A., ... Ocak, B.(2023). Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study. Journal of Cancer Research and Clinical Oncology , vol.149, no.11, 8243-8253.

Bilici, Ahmet Et Al. "Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study," Journal of Cancer Research and Clinical Oncology , vol.149, no.11, 8243-8253, 2023

Bilici, Ahmet Et Al. "Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study." Journal of Cancer Research and Clinical Oncology , vol.149, no.11, pp.8243-8253, 2023

Bilici, A. Et Al. (2023) . "Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study." Journal of Cancer Research and Clinical Oncology , vol.149, no.11, pp.8243-8253.

@article{article, author={Ahmet Bilici Et Al. }, title={Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study}, journal={Journal of Cancer Research and Clinical Oncology}, year=2023, pages={8243-8253} }